ACC 23 Late-breaker Discussion: The BETTER-CARE HF Trial

Published: 05 Mar 2023

  • Views:

    Views Icon 478
  • Likes:

    Heart Icon 1
Average (ratings)
No ratings
Your rating

ACC.23/WCC — Join Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) and investigator, Dr Amrita Mukhopadhyay (NYU School of Medicine, US) in their engaging discussion on the BETTER CARE-HF trial (NCT05275920). 

The BETTER CARE-HF trial investigated the effectiveness of two electronic clinical decision support (CDS) tools to support prescribing proven therapies for heart failure with reduced ejection fraction (HFrEF). 
The trial developed two targeted CDS tools and compared their effectiveness against usual care on the primary outcome of MRA prescribing. The trial included 1,859 patients who were randomized across >50 practices and 180 cardiologists. BETTER CARE-HF is the first study to directly compare the effectiveness of an alert and message to improve prescribing. 

Recorded remotely from Hamilton and New York, 2023.

For more content from ACC.23/WCC and the Late-breaker Discussion series head to Late-Breaking Science Video Collection.

Editor: Mirjam Boros

Video production: Oliver Miles & Dan Brent 


You must be to comment. If you are not registered, you can register here.